These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35427685)

  • 21. Discovery of new adverse drug reactions. A review of the Food and Drug Administration's spontaneous reporting system.
    Rossi AC; Knapp DE
    JAMA; 1984 Aug 24-31; 252(8):1030-3. PubMed ID: 6748207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration.
    Muñoz MA; Delcher C; Dal Pan GJ; Kortepeter CM; Wu E; Wei YJ; Xiao H; Winterstein AG
    Pharmacotherapy; 2019 Nov; 39(11):1042-1052. PubMed ID: 31479525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.
    Reese JA; Li X; Hauben M; Aster RH; Bougie DW; Curtis BR; George JN; Vesely SK
    Blood; 2010 Sep; 116(12):2127-33. PubMed ID: 20530792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serious adverse events in Norplant users related to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Chez RA
    Obstet Gynecol; 1995 Jul; 86(1):154-5. PubMed ID: 7784014
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety profile of drugs for advanced melanoma: A report based on 2008-2018 US Food and Drug Administration Data.
    Casarotto E; Noize P; Létinier L; Salvo F; Pham-Ledard A; Molimard M
    Br J Clin Pharmacol; 2021 Jul; 87(7):2988-2995. PubMed ID: 33294983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 150 years of pharmacovigilance.
    Routledge P
    Lancet; 1998 Apr; 351(9110):1200-1. PubMed ID: 9643710
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparing Different Adverse Effects Among Multiple Drugs Using FAERS Data.
    Huang J; Zhang X; Du J; Duan R; Yang L; Moore JH; Chen Y; Tao C
    Stud Health Technol Inform; 2017; 245():1268. PubMed ID: 29295353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug target prediction using adverse event report systems: a pharmacogenomic approach.
    Takarabe M; Kotera M; Nishimura Y; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i611-i618. PubMed ID: 22962489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Sivin I
    Obstet Gynecol; 1995 Aug; 86(2):318-20. PubMed ID: 7617371
    [No Abstract]   [Full Text] [Related]  

  • 30. Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database.
    Meier L; Wang EY; Tomes M; Redberg RF
    JAMA Intern Med; 2020 Jan; 180(1):147-148. PubMed ID: 31589249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
    Zhou Z; Hultgren KE
    JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.
    Garg V; Raisch DW; McKoy JM; Trifilio SM; Holbrook J; Edwards BJ; Belknap SM; Samaras AT; Nardone B; West DP
    Expert Opin Drug Saf; 2013 May; 12(3):299-307. PubMed ID: 23480866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.
    Bluestein SB; Yu R; Stone C; Phillips EJ
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3208-3211.e1. PubMed ID: 34033979
    [No Abstract]   [Full Text] [Related]  

  • 34. [Analysis of Information on Drug Adverse Reactions Using U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)].
    Nango D; Sekizuka T; Goto M; Echizen H
    Yakugaku Zasshi; 2022; 142(4):341-344. PubMed ID: 35370189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.
    de Bie S; Ferrajolo C; Straus SM; Verhamme KM; Bonhoeffer J; Wong IC; Sturkenboom MC;
    PLoS One; 2015; 10(6):e0130399. PubMed ID: 26090678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ear and labyrinth toxicities induced by immune checkpoint inhibitors: a disproportionality analysis from 2014 to 2019.
    Hu F; Ye X; Zhai Y; Xu J; Guo X; Guo Z; Zhou X; Ruan Y; Zhuang Y; He J
    Immunotherapy; 2020 May; 12(7):531-540. PubMed ID: 32456497
    [No Abstract]   [Full Text] [Related]  

  • 37. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Patel NM; Stottlemyer BA; Gray MP; Boyce RD; Kane-Gill SL
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):309-322. PubMed ID: 33599896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the completeness and accuracy of MedWatch data.
    Getz KA; Stergiopoulos S; Kaitin KI
    Am J Ther; 2014; 21(6):442-6. PubMed ID: 23011177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
    Raschi E; Mazzarella A; Antonazzo IC; Bendinelli N; Forcesi E; Tuccori M; Moretti U; Poluzzi E; De Ponti F
    Target Oncol; 2019 Apr; 14(2):205-221. PubMed ID: 30927173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Litigation-Associated Reports on Signal Identification in the US FDA's Adverse Event Reporting System.
    Muñoz MA; Dal Pan GJ
    Drug Saf; 2019 Oct; 42(10):1199-1201. PubMed ID: 31098918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.